Shanghai Junshi Biosciences Co., Ltd. (SHA:688180)

Market Cap	31.53B +43.1%
Revenue (ttm)	2.48B +38.9%
Net Income	-949.86M
EPS	-0.96
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,419,970
Average Volume	16,115,392
Open	34.87
Previous Close	35.09
Day's Range	34.54 - 35.49
52-Week Range	25.60 - 51.40
Beta	0.79
RSI	43.21
Earnings Date	Mar 14, 2026

About SHA:688180

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 2,670
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688180

Financial Performance

In 2024, SHA:688180's revenue was 1.95 billion, an increase of 29.67% compared to the previous year's 1.50 billion. Losses were -1.28 billion, -43.90% less than in 2023.